Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis.
Molloy SF, Bradley J, Karunaharan N, Mputu M, Stone N, Phulusa J, Chawinga C, Gaskell K, Segula D, Ming D, Peirse M, Chanda D, Lakhi S, Loyse A, Kanyama C, Heyderman RS, Harrison TS. Molloy SF, et al. Among authors: mputu m. AIDS. 2018 Sep 24;32(15):2259-2261. doi: 10.1097/QAD.0000000000001961. AIDS. 2018. PMID: 30102652 Free PMC article. Clinical Trial.
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team. Molloy SF, et al. N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922. N Engl J Med. 2018. PMID: 29539274 Free article. Clinical Trial.
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe.
Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):; Adakun SA, Banda FM, Bloom A, Bochnowicz M, Chakaya J, Chansa A, Chiguvare H, Chimzizi R, Colvin C, Dongo JP, Durena A, Duri C, Edmund R, Harries AD, Kathure I, Kavenga FN, Lin Y, Luzze H, Mbithi I, Mputu M, Mubanga A, Nair D, Ngwenya M, Okotu B, Owiti P, Owuor A, Thekkur P, Timire C, Turyahabwe S, Tweyongyere E, YaDiul M, Zachariah R, Zimba K. Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, et al. Among authors: mputu m. IJTLD Open. 2024 May 1;1(5):197-205. doi: 10.5588/ijtldopen.24.0082. eCollection 2024 May. IJTLD Open. 2024. PMID: 39022778 Free PMC article.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.
Kenya, Uganda, Zambia and Zimbabwe TB Disability Study Group listed by surname alphabetically:; Adakun SA, Banda FM, Bloom A, Bochnowicz M, Chakaya J, Chimzizi R, Dongo JP, Duri C, Harries AD, Kathure I, Kavenga FN, Kumar AMV, Lin Y, Luzze H, Mbithi I, Mputu M, Mubanga A, Mudoola D, Nair D, Ngwenya M, Ntambi S, Owiti P, Owuor A, Thekkur P, Timire C, Tweyongyere E, YaDiul M, Zachariah R. Kenya, Uganda, Zambia and Zimbabwe TB Disability Study Group listed by surname alphabetically:, et al. Among authors: mputu m. IJTLD Open. 2025 May 12;2(5):291-298. doi: 10.5588/ijtldopen.25.0171. eCollection 2025 May. IJTLD Open. 2025. PMID: 40365030 Free PMC article.